GRB2 and leukemia: BP1001 is a dioeoylphosphatidylcholine lipid-encapsulated P-ethoxy-modified ASO that was designed to block the expression of the growth factor receptor-bound protein 2 (GRB2) and, in turn, suppress the activation ERK1 and ERK2 and leukemia progression.